Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Cancer|June 28, 2024
Roadmap for the next generation of Children's Oncology Group rhabdomyosarcoma trialsJonathan L Metts, Jamie M Aye, Jacquelyn N Crane, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 10, 2018
Addition of Vincristine and Irinotecan to Vincristine, Dactinomycin, and Cyclophosphamide Does Not Improve Outcome for Intermediate-Risk Rhabdomyosarcoma: A Report From the Children's Oncology GroupDouglas S Hawkins, Yueh-Yun Chi, James R Anderson, et al.
Skeletal Muscle|May 23, 2019
Preclinical rationale for entinostat in embryonal rhabdomyosarcomaNarendra Bharathy, Noah E Berlow, Eric Wang, et al.
The Lancet. Oncology|February 28, 2020
Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trialsDavid S Hong, Steven G DuBois, Shivaani Kummar, et al.
British Journal of Cancer|March 24, 2023
Functional genomics of human clear cell sarcoma: genomic, transcriptomic and chemical biology landscape for clear cell sarcomaSamuel V Rasmussen, Agnieszka Wozniak, Melvin Lathara, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 24, 2021
Genomic Classification and Clinical Outcome in Rhabdomyosarcoma: A Report From an International ConsortiumJack F Shern, Joanna Selfe, Elisa Izquierdo, et al.
Genetics in Medicine Open|November 1, 2024
Clinical RNA sequencing clarifies variants of uncertain significance identified by prior testingJonathan Marquez, Jennifer N Cech, Cate R Paschal, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 22, 2022
Machine learning for rhabdomyosarcoma histopathologyArthur O Frankel, Melvin Lathara, Celine Y Shaw, et al.
The New England Journal of Medicine|February 22, 2018
Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and ChildrenAlexander Drilon, Theodore W Laetsch, Shivaani Kummar, et al.
Science Signaling|November 22, 2018
The HDAC3-SMARCA4-miR-27a axis promotes expression of the <i>PAX3:FOXO1</i> fusion oncogene in rhabdomyosarcomaNarendra Bharathy, Noah E Berlow, Eric Wang, et al.
Pageof 9